Orinda, CA, United States of America

Barry L Engelstad

This inventor holds 7 USPTO granted patents. Top assignee: University of California. Active years: 1990-1995.


% Patents Active = 100.0

Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 68(Granted Patents)


Company Filing History:


Years Active: 1990-1995

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Barry L Engelstad: Innovator in Magnetic Resonance Imaging

Introduction

Barry L Engelstad is a prominent inventor based in Orinda, CA (US). He has made significant contributions to the field of medical imaging, particularly in magnetic resonance imaging (MRI). With a total of 7 patents to his name, Engelstad's work has advanced diagnostic techniques in healthcare.

Latest Patents

Engelstad's latest patents include innovative methods for enhancing MRI diagnostics. One notable patent focuses on contrast agents for magnetic resonance imaging of the small intestine. This method utilizes contrast agents that provide increased diagnostic information in MRI images of the hepatobiliary system and alimentary tract, especially the small intestine. Another significant patent involves imaging agents for in vivo magnetic resonance and scintigraphic imaging. This patent outlines methods for in vivo imaging using chelated transition metal and lanthanide metal complexes, along with novel ligands for these complexes.

Career Highlights

Barry L Engelstad is affiliated with the University of California, where he continues to contribute to research and development in medical imaging technologies. His work has been instrumental in improving the accuracy and effectiveness of diagnostic imaging.

Collaborations

Engelstad has collaborated with notable colleagues, including John P Huberty and David L White. These partnerships have fostered innovation and have led to advancements in the field of MRI.

Conclusion

Barry L Engelstad's contributions to magnetic resonance imaging have significantly impacted the medical field. His innovative patents and collaborations continue to enhance diagnostic capabilities, ultimately benefiting patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…